» Articles » PMID: 31812571

T-cell Phenotyping Uncovers Systemic Features of Atopic Dermatitis and Psoriasis

Citing Articles

Single-cell mass cytometry in immunological skin diseases.

Zhao M, Cheng Y, Gao J, Zhou F Front Immunol. 2024; 15:1401102.

PMID: 39081313 PMC: 11286489. DOI: 10.3389/fimmu.2024.1401102.


The Immunology of Psoriasis-Current Concepts in Pathogenesis.

Sieminska I, Pieniawska M, Grzywa T Clin Rev Allergy Immunol. 2024; 66(2):164-191.

PMID: 38642273 PMC: 11193704. DOI: 10.1007/s12016-024-08991-7.


Therapeutic effects of mesenchymal stem cells and their derivatives in common skin inflammatory diseases: Atopic dermatitis and psoriasis.

Yang J, Xiao M, Ma K, Li H, Ran M, Yang S Front Immunol. 2023; 14:1092668.

PMID: 36891306 PMC: 9986293. DOI: 10.3389/fimmu.2023.1092668.


Solar UVR and Variations in Systemic Immune and Inflammation Markers.

Mai Z, Byrne S, Little M, Sargen M, Cahoon E JID Innov. 2021; 1(4):100055.

PMID: 34909751 PMC: 8659735. DOI: 10.1016/j.xjidi.2021.100055.


Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis.

Andres-Ejarque R, Ale H, Grys K, Tosi I, Solanky S, Ainali C Nat Commun. 2021; 12(1):4741.

PMID: 34362923 PMC: 8346545. DOI: 10.1038/s41467-021-25066-9.